share_log

ALLARITY THERAPEUTICS INC | DEF 14A: Definitive information statements

SEC announcement ·  Mar 8 06:05
Summary by Moomoo AI
Allarity Therapeutics, Inc. (ALLARITY THERAPEUTICS INC) announced a virtual Special Meeting of Stockholders to be held on April 1, 2024, at 10:00 a.m. Eastern Time. The meeting will be conducted exclusively via live audio webcast. Stockholders as of the record date, February 21, 2024, are entitled to vote on proposals including an amendment to the 2021 Equity Incentive Plan to increase authorized shares, a reverse stock split, and an adjournment proposal if necessary. The reverse stock split aims to increase the per-share market price to comply with Nasdaq's minimum bid price requirement. The board may, at its discretion, determine the reverse stock split ratio between 1-for-5 and 1-for-20. The meeting will also address the potential adjournment to solicit additional proxies if there are insufficient votes for the reverse stock split proposal. Votes will be counted towards the quorum only if a valid proxy is submitted or if the stockholder votes at the meeting. The proposals are designed to enhance stockholder value and maintain Nasdaq listing compliance.
Allarity Therapeutics, Inc. (ALLARITY THERAPEUTICS INC) announced a virtual Special Meeting of Stockholders to be held on April 1, 2024, at 10:00 a.m. Eastern Time. The meeting will be conducted exclusively via live audio webcast. Stockholders as of the record date, February 21, 2024, are entitled to vote on proposals including an amendment to the 2021 Equity Incentive Plan to increase authorized shares, a reverse stock split, and an adjournment proposal if necessary. The reverse stock split aims to increase the per-share market price to comply with Nasdaq's minimum bid price requirement. The board may, at its discretion, determine the reverse stock split ratio between 1-for-5 and 1-for-20. The meeting will also address the potential adjournment to solicit additional proxies if there are insufficient votes for the reverse stock split proposal. Votes will be counted towards the quorum only if a valid proxy is submitted or if the stockholder votes at the meeting. The proposals are designed to enhance stockholder value and maintain Nasdaq listing compliance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more